Global Blood (GBT) Down 15.5% Since Last Earnings Report: Can It Rebound?
nasdaq.com
news
2022-06-03 11:32:00

It has been about a month since the last earnings report for Global Blood Therapeutics (GBT). Shares have lost about 15.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Global Blood due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.

Global Blood Q1 Loss Narrower Than Expected, Revenues Lag

Global Blood incurred a loss of $1.
